UCB S.A.
UCB S.A. (UCBJF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · UCBJF · as of Jun 9, 2026
Key Statistics
Explore UCB S.A. Data
ucbjf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
Competitors & Peers
ucbjf competitorsUCBJF
ARGNF
CMXHF
DSKYF
DSNKY
HLNCFStock Performance
Full HistoryAbout UCB S.A.
UCB S.A. is a prominent biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for individuals affected by neurological and immunological diso…
what is ucb s.a. · ucbjf stock overview · ucb s.a. company profile · who is ucb s.a. ceo · ucbjf OTC · ucb s.a. headquarters · ucb s.a. business segments
About Stock Overview & Key Data
UCB S.A. (UCBJF) is a Healthcare company in the Biotechnology industry, listed on OTC since Aug 26, 2008. As of the latest trading session, UCBJF stock price is $292.14, with a market capitalization of $55.6B. The stock has returned +54.98% over the past 12 months and -0.49% year-to-date.
According to 2 Wall Street analysts, the consensus rating for UCB S.A. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, UCB S.A. reported revenue of $7.7B and net income of $1.6B. For detailed data — including UCB S.A. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, UCB S.A. (UCBJF) stock price is $292.14. The stock is traded on OTC under the ticker symbol UCBJF. The 52-week range is $178.54 – $345.39.